Interestingly, clinical behavior of NB is correlated with high-level amplification of the MYCN oncogene, whose expression was found to inversely relate to lamin A/C expression in tumor-initiating cells (Nardella et al., 2015). This evidence concerns the gene MYCN and neuroblastoma.